Agatha
Private Equity Round in 2025
Founded in 2015, Agatha specializes in providing a content management cloud solution tailored for hospitals, pharmaceutical companies, and clinical research organizations. Its platform streamlines deviation, CAPA, complaints, audit, change control modules, SOP management, documentation collection during studies, and regulatory documentation following the EDM Reference Model.
BioVendor Group
Acquisition in 2025
BioVendor Group is a provider of products and services in the fields of biomedical research, clinical diagnostics, veterinary diagnostics, and food analysis. Through strategic partnerships with companies like Test Line Clinical Diagnostics, BioVendor Instruments, Immunolab, ViennaLab Diagnostics, and Genetrac, the company has built a comprehensive and quality-focused portfolio. This collaboration allows BioVendor Group to cater to professionals in various industries, offering a range of solutions to meet their specific needs and requirements.
Irrimax
Acquisition in 2024
Irrimax Corporation is a medical technology company founded in 2003 and based in Lawrenceville, Georgia. The company specializes in the development, clinical research, manufacture, and commercialization of innovative medical solutions aimed at treating and preventing infections. Its flagship product, Irrisept, is a wound debridement and cleansing system designed to effectively remove bacteria, particulate, and debris from wounds without damaging underlying tissues. By providing these advanced medical technologies, Irrimax seeks to enhance patient outcomes, reduce healthcare costs, and improve the safety of healthcare professionals. The company distributes its products through a network of distributors and suppliers across the United States and operates as a subsidiary of Innovation Technologies, Inc.
WiQo is a professional manufacturer of dermocosmetic products and medical devices headquartered in Trieste, Italy. The company specializes in the development of aesthetic medicines and offers a range of medical products and cosmeceuticals designed to enhance beauty. Among its notable innovations is the patent-protected PRX-T33, a chemical-free stimulation treatment that provides effective results without the use of harsh chemicals. WiQo focuses on combining scientific research with practical applications to meet the needs of its customers in the beauty and healthcare sectors.
Title21
Acquisition in 2022
Title21 Health Solutions is a user-centric and innovative technology that provides fully-integrated and flexible solutions to health science organizations to increase operational efficiency, close compliance gaps, and improve patient care and outcomes. Since 2001, Title21 has created adaptable software products targeted to the unique needs of firms in the regulated life science industry. The flexible and user-friendly technology that made Title21 the go-to quality management platform and is now available to fully-automate cellular therapy environments.
Corealis Pharma
Venture Round in 2022
Corealis Pharma specializes in contract manufacturing services for pharmaceutical and biotech companies. It offers formulation development, clinical trial material manufacturing, and packaging of solid dosage forms, along with supporting services such as API characterization, stability testing, technical transfer, and dossier support.
Natus Medical
Acquisition in 2022
Natus Medical is a prominent provider of healthcare products focused on the screening, diagnosis, treatment, and monitoring of various medical conditions. The company specializes in products for newborn care, hearing impairments, neurological dysfunctions, epilepsy, sleep disorders, and balance and mobility disorders. Natus offers a range of non-invasive medical instruments and disposables, including computerized neurodiagnostic systems for audiology and neurology, as well as newborn care devices such as hearing screening systems, phototherapy equipment for jaundice, head-cooling products for brain injury treatment, and incubators to create optimal environments for newborns. Additionally, Natus provides software solutions for managing and tracking disorders, serving public health laboratories and enhancing the accuracy of patient diagnoses in healthcare settings.
CARSO Group
Acquisition in 2021
Founded in 1992, CARSO Group specializes in environmental and agrifood analytical services. It offers a wide range of accredited laboratory analyses, including water quality, industrial hygiene, forensic samples, and consumer products, ensuring regulatory compliance and public safety across diverse sectors.
Cardioline
Acquisition in 2021
Cardioline is a Milan-based company specializing in the design and manufacture of advanced medical equipment aimed at enhancing global healthcare. The company develops a range of diagnostic and therapeutic devices, including electrocardiographs, ambulatory monitors, and telemedicine applications. These products are designed to provide physicians with reliable tools and medical support, facilitating effective patient treatment. Through its technological innovations and expertise in medical processes, Cardioline contributes to improving healthcare outcomes worldwide.
Cube Biotech
Acquisition in 2021
Cube Biotech specializes in innovative products and solutions for membrane protein research, which is critical for pharmaceutical development. The company operates on a dual business model comprising a service unit focused on the structural analysis of membrane proteins and a product unit that generates consistent revenue. Membrane proteins are vital in the study of various diseases and are key targets in drug discovery, yet their structural analysis remains a significant challenge. Cube Biotech offers a comprehensive range of products, including nanodiscs, purification resins, magnetic beads, protein purification matrices, cell-free lysates, and ultrapure detergents, which facilitate access to essential membrane protein structure information. The company's unique technology positions it advantageously within the market, providing valuable services and products to customers in the pharmaceutical and biotechnological sectors, as well as academia. With over 40 years of combined experience in membrane protein expression, purification, and crystallization, Cube Biotech is well-equipped to advance research in this crucial area, highlighted by the recognition of membrane protein research with the 2012 Nobel Prize in Chemistry.
Xpress Biologics
Acquisition in 2021
Xpress Biologics is a contract manufacturing company that specializes in providing comprehensive services for the pre-clinical production sector. The company offers a wide range of capabilities, including the design of microbial expression systems, the development of upstream and downstream processes, and the implementation of quality control measures for the production of recombinant proteins, antibody fragments, and plasmid DNA. By acting as a one-stop shop, Xpress Biologics supports the vaccine, therapeutic, and diagnostic markets in executing and managing clinical trials, ensuring a streamlined approach to the complexities of biopharmaceutical development.
Suanfarma Biotech
Acquisition in 2021
Suanfarma Biotech engages in the development, manufacture, and distribution of raw materials and finished dosage forms for pharmaceutical, biotechnological, veterinary, nutritional, and cosmetic sectors. It offers generics and active pharmaceutical ingredients, such as anti-infective, cardiovascular system, central nervous system, digestive system, endocrine system, oncology, respiratory system, and pain and inflammation products; and food supplements, and medicinal and dietary plants, including non-native vegetable species, dietary supplements, plant extracts, jellies, syrups, oligotherapy, litotherapy, etc.
Suanfarma Biotech also provides active ingredients for veterinary industry, such as antibiotics, NSAIDs, antiparasitics, glucocorticoids, nutritional, reproduction, and others; and develops alternative routes of synthesis for obtaining active pharmaceutical ingredients and their subsequent industrial scale-up. In addition, it invests in seed and early-stage biotechnology companies; delivers its expertise to biotech companies on issues related to business and commercial management; and provides support on scientific, industrial, regulatory, and financial development.
Suanfarma Biotech serves customers in Spain and internationally. It began operation in 1993, with its headquarters in Alcobendas in Spain and locations in Phoenix in Arizona, Fair Lawn in New Jersey, Naucalpan de Juárez in Mexico; Bogotá in Colombia, Caracas in Venezuela, Sao Paulo in Brazil, Buenos Aires in Argentina, Santiago in Chile, Madrid and Barcelona in Spain, Fitbourg in Switzerland, Dubai in the United Arab Emirates, Navi Mumbai in India, and Shanghai in China.
Stragen
Acquisition in 2021
Stragen is a global player in the development, registration, and distribution of Generic drugs, Consumer Health products, and Original drugs.
Ad-Tech Medical Instrument
Acquisition in 2020
Ad-Tech Medical Instrument Corporation is a prominent manufacturer and distributor of intra-cranial monitoring devices, specifically designed for the treatment of intractable epilepsy and complementary neurosurgical instrumentation. The company's products include a variety of electrode devices, such as subdural strip and grid electrodes, depth electrodes, and cranial nerve electrodes, which are utilized for long-term EEG monitoring, mapping, and brain stimulation. With over 30 years of experience, Ad-Tech is recognized for its innovative designs and high-quality manufacturing, having introduced pioneering techniques like a tunneling method to reduce the risk of cerebrospinal fluid leakage. The depth electrode design is regarded as the gold standard in this field. Ad-Tech’s commitment to using advanced materials and components ensures that its devices meet the needs of neurosurgeons, enhancing ease of use and connectivity. The company has established a strong reputation for performance and safety, continuously expanding its product offerings and maintaining a track record of innovation in neuro-monitoring and neurosurgery.
NAMSA is a medical research organization that offers regulatory, laboratory, clinical, and compliance services to medical device and healthcare product manufacturers. They provide strategic guidance and tactical support throughout the product development process to help clients bring their medical products to market in major global markets. NAMSA prioritizes quality and efficiency, ensuring that clients have a smart strategy in place from the beginning to avoid setbacks. Their expertise and insight make them a trusted partner for navigating the complex landscape of medical product commercialization.
ActiGraph
Acquisition in 2020
ActiGraph is a technology company that develops wearable ambulatory monitoring devices, software, and data analytics for research and clinical use. It produces medical-grade activity and sleep monitoring hardware and offers platforms and analytics tools to collect, manage, and analyze real-world behavioral data across studies and trials. The company's products enable researchers, pharmaceutical firms, and healthcare organizations to measure activity, sleep, and mobility, supporting evidence generation and outcome assessment. Headquartered in Pensacola, Florida, ActiGraph serves a global scientific community with end-to-end digital health technology solutions that integrate hardware, software, and data management to facilitate timely and reliable data for research and clinical decision making.
Direct Healthcare Group
Acquisition in 2019
Direct Healthcare Group designs, manufactures, and supplies healthcare accessories focused on pressure area solutions. They offer a range of products including mattresses, cushions, wheelchairs, and air cushions under brands like DYNA-FORM, KIRTON, and NIGHTINGALE. The company serves community care, nursing homes, and wheelchair services sectors in the UK and internationally.
Eurolyser Diagnostica
Acquisition in 2019
Eurolyser Diagnostica GmbH is a Salzburg-based company that specializes in the development, manufacture, and distribution of medical diagnostics. The company focuses on point-of-care testing devices and kits for both human and veterinary use. By providing healthcare professionals with rapid and precise diagnostic tools, Eurolyser aims to enhance the efficiency of patient care. Its products enable doctors to make timely decisions and initiate treatment without relying heavily on laboratory facilities, thus streamlining the healthcare process. Eurolyser's commitment to advancing medical diagnostics plays a vital role in modern healthcare management.
Diesse
Acquisition in 2019
Diesse is an Italian developer of innovative in vitro diagnostic (‘IVD’) systems for the diagnosis of infectious and autoimmune diseases.
Bomi Group
Acquisition in 2019
Bomi Group specializes in logistics services tailored for the diagnostic and medical sectors. It facilitates global distribution of healthcare products through transport, warehousing, and supply chain management solutions.
Clean Cells
Venture Round in 2018
Clean Cells SAS, based in Boufféré, France, provides essential services for the biopharmaceutical industry, focusing on quality control, safety testing, and product development. Founded in 2000, the company specializes in viral and biological safety testing for various biopharmaceuticals, including recombinant proteins, therapeutic antibodies, vaccines, and cell and gene therapies. Clean Cells also produces GMP-grade cell and virus banks and offers secure storage solutions in liquid and gaseous nitrogen. Additionally, the company engages in biobanking and custom-made tests required by international regulatory bodies to ensure the safety of biological products throughout production. With a commitment to advancing personalized medicine, Clean Cells seeks to play a significant role in developing new therapies, including innovative experimental drugs like cell therapy products and therapeutic phages.
Provepharm life Solutions
Acquisition in 2018
Provepharm Life Solutions SA is a life sciences company based in Marseille, France, specializing in contract research and development services for small molecules and therapeutic peptides. Founded in 1998, the company focuses on the development, manufacturing, and marketing of pharmaceutical products and active ingredients. A key offering is pharmacopoeial grade methylene blue, a versatile compound utilized in various human health applications, including as an antidote for methemoglobinemia, a mild urinary antiseptic, and a topical antiseptic. The company also addresses animal health needs, providing solutions for toxicosis and aquaculture. Methylene blue serves additional roles as a laboratory dye, indicator, and diagnostic aid in surgical procedures. Provepharm Life Solutions aims to lead in the life sciences sector through its innovative approach, known as Molecule Vitalization, and offers a range of research and manufacturing services to advance health solutions.
Soest Medical Group
Acquisition in 2018
Soest Medical Group is a manufacturer of medical supplies based in Soest, the Netherlands, specializing in self-adhesive products designed to secure protective drapes to patients' skin during surgical procedures. Established in 1990, the company focuses on developing both reusable and disposable surgical covering materials that cater to the needs of hospitals and medical care institutions. Through collaboration with universities and hospitals, Soest Medical Group emphasizes research and development to enhance its product offerings and ensure optimal solutions for its clients. The company is dedicated to maintaining strong connections with its customers, prioritizing care and responsiveness in its approach to product innovation and customization.
Fytexia
Acquisition in 2016
Fytexia is a supplier of innovative and scientifically proven natural ingredients for the international nutraceutical industry, located in the South of France along the Mediterranean Sea. The company specializes in diet polyphenols, antioxidants, and nutritional supplements, aiming to provide health benefits linked to the Mediterranean diet. By focusing on the development of products that help reduce risk factors for non-communicable diseases, Fytexia serves clients in the food supplement sector with solutions that are both effective and clinically validated.
Polyplus-transfection
Acquisition in 2016
Polyplus-transfection SA is a biotechnology company based in Illkirch-Graffenstaden, France, specializing in the development and sale of solutions for nucleic acid delivery across research, bioproduction, and therapeutic applications. Established in 2001 and ISO 9001-certified since 2002, the company offers a diverse range of proprietary reagents for the transfection of genes, oligonucleotides, and siRNA. These products facilitate various applications including enhanced in vivo delivery, molecular biology, diagnostics, gene expression, RNA interference, and protein production. Polyplus-transfection's reagents are increasingly utilized in clinical trials globally, supported by a network of distributors. The company also holds a comprehensive portfolio of patents and licenses, featuring innovative methods for therapeutic siRNA delivery.
Micromed
Acquisition in 2016
Micromed is an Italian company specializing in the manufacture of electro medical devices for neurophysiology diagnostics. It produces a comprehensive range of neurodiagnostic systems that include long-term monitoring (LTM), intensive care unit (ICU) equipment, electroencephalography (EEG), electromyography (EMG), and polysomnography (PSG). These products enable healthcare providers to monitor the electrical activity of the brain, muscles, and nerves, supporting accurate diagnosis and treatment in the field of neurology.
Herb's International Service
Acquisition in 2016
Herb's International Service is a French leader in natural health ingredients.
A team of 25 people who are passionate with botanicals.
An agile company expert in sourcing herbal raw material.
Sourcing means genuine quality, traceability, environment and ethical practices.
We are audited each year by Ecocert and we have been granted the excellence label as a responsible company.
We believe in partnership and work closely with our farmers, contract manufacturers to deliver the best ingredients to our customers.
We design many type of natural ingredients using our raw material and we share our expertise with you.
Service is key for us. We are dedicated to your projects.
Vita Health Group
Acquisition in 2015
Vita Health Group Limited is a healthcare organization based in Bury St. Edmunds, United Kingdom, that specializes in injury management and rehabilitation services for the industry and insurance sectors. Founded in 1987, the company provides a comprehensive range of services including preventative care, occupational health, physiotherapy, psychological therapy, case management, and functional restoration. Vita Health Group employs a biopsychosocial approach to address both physical and mental health conditions, focusing particularly on musculoskeletal disorders. By integrating workplace involvement into the recovery process, the company effectively reduces absenteeism and demonstrates significant financial savings for its clients, which include insurers, employers, and government entities. With its emphasis on delivering end-to-end solutions, Vita Health Group has established itself as a leader in occupational treatment programs and workplace wellness initiatives.
Deallus
Acquisition in 2015
Deallus is a global management consultancy specializing in the life sciences sector. It provides strategic intelligence consulting services, assisting clients in making informed decisions and gaining competitive advantages through expert advice on product introduction strategies and innovation processes.
Centri Dentistici Primo
Venture Round in 2015
Centri Dentistici Primo operates a network of dental clinics across Italy, providing a comprehensive range of dental services. Their offerings include hygiene and conservation, implantology, prosthetics, orthodontics, endodontics, and periodontology, allowing them to cater to a diverse clientele of all ages. The company emphasizes trust and transparency in its patient relationships, ensuring that care is delivered with seriousness and clarity. This commitment to personalized treatment underscores their approach to dentistry, aiming to foster sincere connections between staff and patients while addressing a variety of dental needs.
Centri Dentistici Primo
Private Equity Round in 2015
Centri Dentistici Primo operates a network of dental clinics across Italy, providing a comprehensive range of dental services. Their offerings include hygiene and conservation, implantology, prosthetics, orthodontics, endodontics, and periodontology, allowing them to cater to a diverse clientele of all ages. The company emphasizes trust and transparency in its patient relationships, ensuring that care is delivered with seriousness and clarity. This commitment to personalized treatment underscores their approach to dentistry, aiming to foster sincere connections between staff and patients while addressing a variety of dental needs.
citieffe s.r.l.
Venture Round in 2014
Citieffe s.r.l. is an Italian company founded in 1962, located in Calderara di Reno. It specializes in the design and manufacture of surgical instruments, focusing on innovative and patented medical products. The company is known for its development of intramedullary nails for trochanter fractures and advanced external fixation devices aimed at reconstructive surgery. Through its commitment to quality and innovation, Citieffe s.r.l. serves the medical community by providing essential tools for surgical procedures.